Wesana Health Holdings Inc. (WSNAF)

Wesana Health Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Other Revenue	-	-	-	-	0.03
Revenue	-	-	-	-	0.03
Cost of Revenue	-	-	-	-	0.02
Gross Profit	-	-	-	-	0.01
Selling, General & Admin	0.39	1.01	3.06	4.68	0.07
Research & Development	-	-	-	-	0.03
Operating Expenses	0.39	1.01	3.06	4.68	0.1
Operating Income	-0.39	-1.01	-3.06	-4.68	-0.09
Interest Expense	-0.07	-0.01	-0.08	-	-
Interest & Investment Income	-	0.02	0.06	-	-
Currency Exchange Gain (Loss)	-0.01	-0.01	-	-0.05	-
Other Non Operating Income (Expenses)	-0.04	-0.1	-0.21	-0.08	-
EBT Excluding Unusual Items	-0.51	-1.1	-3.3	-4.8	-0.09
Gain (Loss) on Sale of Investments	-0.16	-0.57	-0.01	-	-
Other Unusual Items	0.13	-0.35	0.14	-1.54	-
Pretax Income	-0.54	-2.03	-3.17	-6.34	-0.09
Earnings From Continuing Operations	-0.54	-2.03	-3.17	-6.34	-0.09
Earnings From Discontinued Operations	-0.59	0.3	-5.43	-28	-
Net Income	-1.13	-1.72	-8.6	-34.34	-0.09
Net Income to Common	-1.13	-1.72	-8.6	-34.34	-0.09
Shares Outstanding (Basic)	35	35	34	23	5
Shares Outstanding (Diluted)	35	35	34	23	5
Shares Change (YoY)	0.05%	1.92%	48.49%	384.77%	-
EPS (Basic)	-0.03	-0.05	-0.25	-1.48	-0.02
EPS (Diluted)	-0.03	-0.05	-0.25	-1.48	-0.02
Gross Margin	-	-	-	-	33.52%
Operating Margin	-	-	-	-	-288.67%
Profit Margin	-	-	-	-	-288.67%
EBITDA	-	-	-3.03	-4.64	-
D&A For EBITDA	-	-	0.04	0.04	-
EBIT	-0.39	-1.01	-3.06	-4.68	-0.09
EBIT Margin	-	-	-	-	-288.67%
Revenue as Reported	-	-	-	-	0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.